The effect of royal jelly on prevention of postmenopausal bone loss

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2015
INTERVENTION: Freeze dried law royal jelly 3,000mg/day (1,000mg as active ingredient) for 6 months. Placebo CONDITION: Postmenopausal bone loss PRIMARY OUTCOME: Bone mineral density, bone turnover markers INCLUSION CRITERIA: Healthy women (without risks of fracture) within 5 years of post‐menopause.
Epistemonikos ID: 58c4e3936d4fff576fc244ffe606c5716cc989d9
First added on: Aug 23, 2024